4 articles tagged
Pharmaceutical firm Eli Lilly is partnering with Nvidia to build an AI-powered supercomputer, aiming to accelerate the discovery of new medicines for various diseases.
Generative AI is rapidly transforming healthcare by automating clinical support, accelerating drug discovery, and streamlining administrative tasks for doctors.
Researchers have discovered a new antibiotic, enterololin, using AI. It targets harmful gut bacteria linked to IBD while sparing the beneficial microbiome.
Bristol Myers Squibb, Takeda, and Astex Pharmaceuticals are joining a consortium to share data for training an AI model aimed at accelerating drug discovery.
